Kyowa Kirin International plc.

Kyowa Kirin International plc. is a rapidly growing specialty biopharmaceutical company dedicated to addressing unmet medical needs and making a positive impact on patients' lives. With a strong commitment to life, Kyowa Kirin International plc. focuses on the development and commercialization of innovative medicines in key therapy areas, including oncology, nephrology, and central nervous system (CNS) disorders. Operating across Europe and the Middle East, Kyowa Kirin International plc. is driven by a passionate team of over 700 people who strive to deliver effective healthcare solutions.

Headquartered at Galabank Business Park, Galashiels, Selkirkshire TD1 1QH, GB, with an additional location at 2 Globeside, Fieldhouse Lane, Marlow, Buckinghamshire SL7 1HZ, GB, Kyowa Kirin International plc. benefits from a rich history of scientific discovery and collaborative partnerships. As a subsidiary of Kyowa Kirin Co., Ltd. (KKC) of Japan, Kyowa Kirin International plc. leverages expertise in antibody engineering and cutting-edge research to develop new molecules with the potential to transform healthcare. The company's core values of commitment to life, innovation, integrity, and teamwork are at the heart of its mission to improve patient outcomes and enhance overall well-being.

Kyowa Kirin International plc. is dedicated to making people smile through its unwavering focus on developing and delivering innovative medicines. With a strong legacy and an exciting future, Kyowa Kirin International plc. continues to seek opportunities to expand its impact on the global healthcare landscape. The company's management is currently compiling detailed information to further showcase its capabilities and contributions to the industry. We invite the manager of Kyowa Kirin International plc. to create a customized and exclusive company showcase and product listing on our platform.